Shanghai Pharmaceuticals Holding Co., Ltd Stock
Stocks
601607
CNE000000C82
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Shanghai S.E.
2026-09-15
|
5-day change | 1st Jan Change | ||
| 16.21 CNY | -0.86% |
|
-2.05% | -9.24% |
| 09-10 | Shanghai Pharmaceuticals Subsidiary Gets China Approval for Antibiotic | MT |
| 09-10 | Shanghai Pharmaceuticals Declares Interim Dividend | MT |
| Market Cap | 53.88B 8.02B 6.95B 6.57B 5.95B 11.17B 770B 11.25B 78.42B 30.17B 390B 30.14B 29.47B 1,245B | P/E 2026 * |
10.7x | P/E 2027 * | 10x |
|---|---|---|---|---|---|
| Enterprise Value | 56.58B 8.43B 7.3B 6.9B 6.25B 11.73B 808B 11.82B 82.36B 31.69B 410B 31.65B 30.95B 1,307B | EV / Sales 2026 * |
0.19x | EV / Sales 2027 * | 0.21x |
| Free-Float |
41.21% | Yield 2026 * |
2.83% | Yield 2027 * | 2.99% |
| 1 day | -0.86% | ||
| 1 week | -2.05% | ||
| Current month | -0.25% | ||
| 1 month | -2.29% | ||
| 3 months | -0.80% | ||
| 6 months | -6.25% | ||
| Current year | -9.24% |
| 1 week | 16.15 |  | 16.58 |
| 1 month | 16.03 | | 16.75 |
| Current year | 15.01 | | 18.13 |
| 1 year | 15.01 | | 18.56 |
| 3 years | 15.01 | | 23.2 |
| 5 years | 15.01 | | 28.64 |
| 10 years | 15.01 | | 29.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ya Dong Zhou
DFI | Director of Finance/CFO | 54 | 2026-06-24 |
Yong Zhong Li
PSD | President | 56 | 2023-06-28 |
Bo Shen
DFI | Director of Finance/CFO | 53 | 2013-06-04 |
| Director | Title | Age | Since |
|---|---|---|---|
Bo Shen
BRD | Director/Board Member | 53 | 2016-06-27 |
Yong Zhong Li
BRD | Director/Board Member | 56 | 2019-06-26 |
Ming Dong
BRD | Director/Board Member | 49 | 2023-06-28 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 4/17/25 | Other | Chairperson | 132,600 | 0.0144% | ||
| 4/17/25 | Other | Chairperson | 132,600 | 0.0144% | ||
| 4/18/24 | Other | Chairperson | 128,700 | 0.0067% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.86% | -2.05% | -9.99% | -9.49% | 8.1B | |
| -1.25% | +1.17% | +27.98% | +114.11% | 106B | |
| -0.95% | -3.26% | +54.82% | +165.13% | 54.63B | |
| 0.00% | -1.49% | -12.00% | +242.86% | 21.58B | |
| -1.02% | -3.71% | -38.97% | -33.71% | 6.91B | |
| -6.81% | -4.59% | -2.76% | +15.61% | 6.81B | |
| -1.69% | -4.67% | -21.20% | -29.65% | 6.11B | |
| -1.08% | -0.18% | -5.82% | +19.22% | 5.08B | |
| -9.95% | -20.07% | +260.63% | +394.49% | 4.14B | |
| +0.92% | +0.72% | +10.33% | +10.56% | 3.89B | |
| Average | -2.26% | -2.53% | +26.30% | +88.91% | 22.35B | |
| Weighted average by Cap. | -1.33% | -3.16% | +28.19% | +124.27% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 296B 44.13B 38.23B 36.15B 32.72B 61.42B 4,233B 61.88B 431B 166B 2,146B 166B 162B 6,845B | 313B 46.68B 40.43B 38.23B 34.61B 64.96B 4,478B 65.45B 456B 176B 2,270B 175B 171B 7,241B |
| Net income | 5.64B 839M 727M 687M 622M 1.17B 80.5B 1.18B 8.2B 3.16B 40.82B 3.15B 3.08B 130B | 5.93B 883M 765M 723M 655M 1.23B 84.67B 1.24B 8.63B 3.32B 42.93B 3.32B 3.24B 137B |
| Net Debt | 2.71B 403M 349M 330M 299M 561M 38.68B 565M 3.94B 1.52B 19.61B 1.51B 1.48B 62.55B | 12.55B 1.87B 1.62B 1.53B 1.39B 2.6B 179B 2.62B 18.27B 7.03B 90.9B 7.02B 6.86B 290B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-15 | CN¥16.21 | -0.86% | 8,107,800 |
| 26-09-14 | CN¥16.35 | +0.37% | 7,105,388 |
| 26-09-11 | CN¥16.29 | -0.12% | 8,709,270 |
| 26-09-10 | CN¥16.31 | -1.03% | 6,928,409 |
| 26-09-09 | CN¥16.48 | -0.54% | 5,625,873 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 601607 Stock
Select your edition
All financial news and data tailored to specific country editions
